Home Page: Annals of Oncology
WEB4 days ago · Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.
Annals of Oncology | Journal | ScienceDirect.com by Elsevier
WEBAnnals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.
Current Issue Table of Contents: Annals of Oncology
WEBAug 12, 2024 · Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis.
Annals of Oncology
WEBFeb 19, 2022 · Abstract Book of the European Lung Cancer Congress (ELCC) 2022, 30 March - 2 April 2022. Publication of this Abstract book is supported by the ELCC 2022 organisers: the European Society for Medical Oncology and the International Association for the Study of Lung Cancer.
Annals of Oncology | All Journal Issues - ScienceDirect
WEBRead the latest articles of Annals of Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature.
Annals of Oncology - Wikipedia
WEBThe Annals of Oncology is a peer-reviewed medical journal of oncology, published by Elsevier. It is the official journal of the European Society for Medical Oncology. The editor-in-chief is Fabrice André ( Villejuif, France ).
Annals of Oncology | Vol 33, Issue 1, Pages 1-118 (January 2022 ...
WEBRead the latest articles of Annals of Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature.
About Annals of Oncology Impact factor: 32.976 - ESMO
WEBAnnals of Oncology is a multidisciplinary journal publishing articles addressing medical oncology in particular, but also surgery, radiotherapy, paediatric oncology, basic research and the comprehensive management of patients with malignant diseases.
List of Issues - Annals of Oncology
WEBOsimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study.
Management of toxicities from immunotherapy: ESMO Clinical …
WEBAnn Oncol. 2022 Dec;33(12):1217-1238. doi: 10.1016/j.annonc.2022.10.001. Epub 2022 Oct 18.
Skip to content